{"title":"Methylation levels in keratinocyte basal cells reflect donor age and associate with altered cellular proliferation pathways.","authors":"Vasiliki Salameti, Ines M Tomas, David A Gunn","doi":"10.1080/17501911.2025.2526320","DOIUrl":null,"url":null,"abstract":"<p><strong>Aims: </strong>To determine if epigenomic and mRNA associations with donor age are present in basal keratinocytes <i>in vitro</i>.</p><p><strong>Methods: </strong>Whole-genome methylation (EPIC array), RNAseq analysis, and in vitro cell growth assessments were performed on cultured keratinocytes (<i>n</i> = 9, 22-68 years), enriched for cells expressing the stem cell protein markers ITGB1 and EpCAM.</p><p><strong>Results: </strong>Donor age associated with 1,244 differentially methylated positions (DMPs) (<i>p</i> < 0.01, >20% delta beta) and correlated with estimated ages from the Skin and Blood epigenetic clock (<i>r</i> = 0.83, <i>p</i> = 0.0018). The DMPs correlated with those in an <i>in vivo</i> epidermal dataset (<i>r</i> = 0.71, <i>p</i> < 0.0001). Donor age associated (<i>p</i> < 0.05) with 523 differentially expressed genes (DEGs), but the DEGs only weakly correlated with their changes in an <i>in vivo</i> epidermal dataset (<i>r</i> = 0.24, <i>p</i> < 0.0001). The \"cell growth and proliferation\" ontology term was significantly enriched in the methylation and expression datasets despite only 13 overlapping annotated genes. Decreased keratinocyte proliferation, increased differentiation and a reduced re-epithelialization ability were observed for an older versus a younger cell strain.</p><p><strong>Conclusion: </strong>Basal keratinocytes maintain <i>in vivo</i> age-associated epigenomic changes <i>in vitro</i> making them a good model for studying the impact of age-associated epigenomic changes on cellular function and behavior <i>in vitro</i>.</p>","PeriodicalId":11959,"journal":{"name":"Epigenomics","volume":" ","pages":"1-9"},"PeriodicalIF":3.0000,"publicationDate":"2025-07-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Epigenomics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/17501911.2025.2526320","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"GENETICS & HEREDITY","Score":null,"Total":0}
引用次数: 0
Abstract
Aims: To determine if epigenomic and mRNA associations with donor age are present in basal keratinocytes in vitro.
Methods: Whole-genome methylation (EPIC array), RNAseq analysis, and in vitro cell growth assessments were performed on cultured keratinocytes (n = 9, 22-68 years), enriched for cells expressing the stem cell protein markers ITGB1 and EpCAM.
Results: Donor age associated with 1,244 differentially methylated positions (DMPs) (p < 0.01, >20% delta beta) and correlated with estimated ages from the Skin and Blood epigenetic clock (r = 0.83, p = 0.0018). The DMPs correlated with those in an in vivo epidermal dataset (r = 0.71, p < 0.0001). Donor age associated (p < 0.05) with 523 differentially expressed genes (DEGs), but the DEGs only weakly correlated with their changes in an in vivo epidermal dataset (r = 0.24, p < 0.0001). The "cell growth and proliferation" ontology term was significantly enriched in the methylation and expression datasets despite only 13 overlapping annotated genes. Decreased keratinocyte proliferation, increased differentiation and a reduced re-epithelialization ability were observed for an older versus a younger cell strain.
Conclusion: Basal keratinocytes maintain in vivo age-associated epigenomic changes in vitro making them a good model for studying the impact of age-associated epigenomic changes on cellular function and behavior in vitro.
期刊介绍:
Epigenomics provides the forum to address the rapidly progressing research developments in this ever-expanding field; to report on the major challenges ahead and critical advances that are propelling the science forward. The journal delivers this information in concise, at-a-glance article formats – invaluable to a time constrained community.
Substantial developments in our current knowledge and understanding of genomics and epigenetics are constantly being made, yet this field is still in its infancy. Epigenomics provides a critical overview of the latest and most significant advances as they unfold and explores their potential application in the clinical setting.